Cargando…
Intratumoral administration of the antisecretory peptide AF16 cures murine gliomas and modulates macrophage functions
Glioblastoma has remained the deadliest primary brain tumor while its current therapy offers only modest survival prolongation. Immunotherapy has failed to record notable benefits in routine glioblastoma treatment. Conventionally, immunotherapy relies on T cells as tumor-killing agents; however, T c...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930985/ https://www.ncbi.nlm.nih.gov/pubmed/35301393 http://dx.doi.org/10.1038/s41598-022-08618-x |